Four layers, counted in order. Where prevention is supposed to happen, why the layer that should carry it keeps stalling, and what I gave up in order to build the one that's missing.
The argument in the piece before this one was that longevity has been built at the wrong end. Marble, peptides, waiting lists for the very rich. The space nobody has taken sits underneath all of that: a proper prevention and early detection layer for adults who are still well, still working hard, and would rather not leave their fifties and sixties to luck.
The response surprised me. Doctors wrote in about what a ten minute appointment can and can't hold. People running clinics and retreats wanted to know which layer they were standing in. Founders wanted to know whether the middle was a category with a business inside it, or a phrase that simply reads well on a slide.
Three questions came back again and again. What does Tier-2 actually mean. Is that not just concierge medicine. And if people want it, why has nobody built it. This piece answers all three, and explains why I gave up on the luxury clinic I originally set out to build.
This is an educational and strategic perspective, not personal medical advice. The views are the author's own and not statements by Atlas Cove Lda.
Four layers, and the order matters
Start with a map. Health for working adults sits in four layers, and I always count them the same way, from zero up to three.
Tier-0: the noise you already live in
This is where most informed adults are right now. Podcast episodes. Threads. Protocols off YouTube. A cupboard of supplements that could pass for a small dispensary. A wrist that vibrates at you. The occasional panicked blood panel ordered to look at everything at once.
None of it is useless. Any of it could feed a proper programme. The trouble is where it all ends up. The information settles in apps and in your nervous system, never in a plan that anyone is accountable for.
Tier-1: paying for access, and for the room
Concierge practices. Memberships. The executive check-up. The clinic with the word longevity above the door.
What you're buying is fewer names on the doctor's list, a longer appointment, someone who answers, and better surroundings. Some outstanding clinicians work here. The architecture underneath is still the one you already know, with more minutes and more tests attached to it. Access is the product. Prevention as a designed system isn't.
Tier-2: the layer that isn't there
Here is the definition I work from. Tier-2 means prevention and early detection done properly for adults who are still functioning, kept outside the hospital, tied to what the evidence supports, and designed to be repeated rather than staged once.
It isn't a week of inspiration, and it isn't a document with sixty lifestyle tips in it. Think of it as the machinery that keeps you out of Tier-3:
preparation done before anybody arrives anywhere
diagnostics carried out properly, and in person
a protocol that somebody designed, rather than a pile of tests that accumulated
months of follow-through shaped around a real job and a real family
It's the layer that converts I'll sort that out at some point into a health strategy with a date on it.
Tier-3: when something is already happening
Hospitals. Emergency departments. Oncology, cardiology, intensive care. The layer whose job is to stop you dying, or losing something you can't get back, once the serious thing has already started.
Treat your health as capital and only one of these four layers is compulsory. Tier-3 has to exist. Nobody wants a life spent inside Tier-0 noise, and nobody sane wants to become a permanent tourist in Tier-1. As for Tier-3, the aim is to arrive there late and rarely. Tier-2 is the layer that improves those odds.
Every system says prevention. Look at where it lands.
On paper the shift has already happened. Advanced health systems have national plans for cancer and for cardiovascular disease, and the vocabulary never varies: early detection, risk stratification, lifestyle change, the health check.
Then look at who is expected to carry all of it. Almost every part lands on primary care.
Here in Portugal, more than a million people registered with the national system have nobody assigned to them as a family doctor. Anyone who does have one is sharing them with thousands of others. Appointments are short, the lists are long, and much of the time left over goes on paperwork, repeat prescriptions, and whatever walked in acutely that morning.
This isn't a failure of doctors. It's a failure of geometry. Deep, personalised prevention can't be run through ten minute slots, lists that never clear, and payment rules written for acute illness. No amount of goodwill changes that arithmetic.
Now watch where private money goes instead. Diagnostics and health screens that people pay for themselves keep expanding. Concierge and direct care are becoming ordinary at the top end. Travelling somewhere for the sake of your health stopped being a curiosity and became a category.
Prevention is handled, in the deck. In practice, serious adults are quietly opting out and improvising something of their own. Tier-2 belongs in that distance, between what the system says it does and what people actually do.
The working definition, unpacked
The sentence I keep coming back to: Tier-2 maps your cardiometabolic risk, your functional capacity, your sleep, your mental load and the cancer risks that are relevant to you, then runs you through a designed programme with enough depth to shift risk and enough discipline to stay safe.
Three parts of that are doing the work, and each is a place where offers in this space tend to quietly fall short.
Map what matters, and only that
Sleep. Functional capacity. Cardio-metabolic risk. Mental health. The cancers whose risk follows from age, sex and what runs in the family. Every test chosen because there's real human evidence behind it, and not because the machine happens to be in the building.
Run a process that somebody designed
Not whatever can be billed. Not a buffet of scans. A protocol that survives contact with your flights, your children and your deadlines, rather than one written for an imaginary version of you who has nothing else on.
Own what happens next
Hand-offs that are clear. Coaching and habit work at the points where they actually change something. And three answers settled in advance: whose job it is to act on a result, what the response is when something looks worrying, and how escalation genuinely runs.
What Tier-2 isn't matters just as much.
Not a spa that also hands you a lab invoice.
Not a small hospital handling serious disease behind a boutique front.
Not your family doctor with a slightly longer slot.
Not longevity content with supplements attached to the back of it.
Red flag test. The people I'm designing for run three filters, and they run them fast. Do not waste my time. Do not talk nonsense. Do not assume I live like a monk or train like a professional. Anything failing one of those is gone by the second conversation. Tier-2 has to clear that bar deliberately, because it will never clear it by accident.
Why I walked away from the clinic I wanted to build
None of this began as a plan for the middle. I was fixated on the top.
My moodboards were full of Swiss and Austrian clinics. The plan was simple enough: put one of those in Portugal. The building, the frontier equipment, food at Michelin level, the entire script as written. Three things took it apart.
Tradeoff: the model works once, then it stops
A single hyper-premium clinic in Portugal does add up on a spreadsheet. Model that same clinic repeated across cities and countries and it turns slow and brittle. What you end up owning is a handful of very expensive boxes, serving a very small number of people.
That isn't the goal. Owning the nicest clinic in any particular city was never the point. I want to bend the health path of a serious number of working adults, and one marble box with a waiting list doesn't do that at any speed worth having.
Once I admitted that, Tier-1 stopped looking like infrastructure and started looking like a brand asset.
Evaluation lens: could I defend it in a hard room
The seductive part of longevity is the frontier. Drips. Exotic compounds. Stacks. Protocols still being worked out in public.
Some of it genuinely helps in specific situations. Some of it looks promising. A lot of it is mechanistic reasoning, small uncontrolled studies, or marketing wearing the costume of evidence. I've written before about the drips flowing while the basics go undone, and the filter I applied here was the same one: strip out anything I couldn't defend to a tough clinician, or to a serious investor.
What survived was diagnostics, designed programmes, behaviour, environment, follow-through. Less magic in it. Rather more engineering. You can build a company on a spine like that.
Boundary: I wouldn't have been the repeat customer
I've put in the work, built a career, and been paid properly for it. I'm also a mother, and nowhere near the ultra-high-net-worth bracket.
Twenty thousand euros for a reset week, repeated every second year, sitting at the centre of my health plan: I can't make that add up, even in a year when stretching to it once would be possible. It doesn't match how I think about risk, or money, or fairness.
I don't want to sell something I wouldn't buy again with a straight face. I'd rather build the thing that someone like me can put on the annual budget as an ordinary line item instead of a splurge.
Put the three filters together and they push in one direction. A model that scales across places and cohorts. A core product resting on evidence that's decent or better. A price and a format that people like me would use more than once. Apply all three and you land in Tier-2: repeatable, exportable, considerably less photogenic, and precisely the thing that's missing.
Is concierge medicine already doing this?
It's the closest thing on the market, and it stops around halfway.
Concierge and membership models generally sell a shorter list, a longer visit and easier access. Direct primary care strips out some of the billing distortion. Executive programmes wrap tests and consultations into something they call a deep dive.
All of that's a real improvement, and it settles one question for good: people will pay for attention. The demand isn't hypothetical.
Structurally, though, most of what I look at shows the same four things.
Access and time are the product. Prevention is present, but it isn't the thing organising the offer.
Prevention is opportunistic. While you're here, shall we also check. That's a good intention. It isn't a programme.
The test menu is mixed. Screening that follows guidelines sits next to scans and panels that are explicitly not recommended, which adds noise and raises the risk of overdiagnosis.
The outcome data is thin. Uptake of preventive services goes up. So does satisfaction. What nobody can show consistently is strokes avoided, cancers caught before they turn late, or functional years added.
So the shape exists in the wild, in fragments, and those fragments confirm part of the demand. An expensive family doctor with extras bolted on is a different animal from a system built, from the first day, to shift risk across a lot of people. The gap sits right there, and that's the one I'm going after.
Four constraints that have to be cleared at once
If the middle is this obvious, the fair question is why it hasn't already become a category with names in it.
Because you can't take Tier-1, dress it in prevention language, and expect the result to survive contact with reality. A serious build has to clear four constraints simultaneously, and most concepts fall over on the second or the third.
1. Regulatory altitude
Regulators look at what you do. What you call yourself isn't the question.
Bring certain diagnostics or therapies under your own roof and, on paper, you start to resemble a hospital. That triggers hospital grade requirements for the facility, the staffing and the oversight. For Tier-3 that's exactly right. For a small Tier-2 operation that never planned for it, it's fatal.
So you choose your altitude on purpose. What never happens in your building. What only ever happens through a formal partner. And the precise point where your responsibility ends and somebody else's begins.
2. Reimbursement
The value in Tier-2 lives in the integration and in the programme. Fee schedules aren't built to see either.
Individual pieces may well be billable. The thing as a whole usually isn't. So it starts as a cash product, sold to people for whom health is already a planned expense and not something remembered late.
If it proves out, other ways of funding it can follow. What you can't do is build the model on the assumption that somebody else will pay for it from the start.
3. Clinician time
Doctor hours are the binding constraint almost everywhere. A model that quietly assumes an unlimited supply of them has already failed. It simply doesn't know yet.
Doctors belong on the decisions: classifying risk, interpreting, escalating, and knowing when to stand down again. Gathering data, teaching, changing habits and monitoring have to be carried by other people and by systems. Design for that on day one, or retrofit it later in a panic.
4. Liability and pathways
More testing produces more findings, and every finding is a responsibility.
If you don't know in advance what you will do with a result, you have lit a fuse. So Tier-2 has to stay conservative about which tests it runs, for what reason, and whose job it is to act when something serious appears.
That discipline markets badly and defends brilliantly. Full body scanning is far easier to sell. A defensible rationale for every test, paired with an escalation route that holds up, takes a long time to reproduce and can't be faked at all. Which is precisely why it's the moat.
None of these four is an argument against building. They're the reason the glossy concepts haven't lasted, and they're where the long-term defensibility sits.
Who this is for, once the friction is respected
Respect that stack of constraints and Tier-2 for everybody disappears immediately. What is left is smaller and sharper, and it's real. Two engines, three groups.
Engine one: professionals who already move
Group one, health literate professionals in the big cities. They're already paying for the executive check-up, private imaging, extended blood work, some flavour of concierge or direct care. They stopped relying on Tier-3 alone some time ago. What they don't have is a risk story that holds together over years, and a plan that fits the life they're actually living.
Group two: worn out executives, and remote workers who already fly somewhere for their health. They book a week in Switzerland, Spain or the Middle East to reset. Spending meaningfully on health isn't a new idea to them. Willingness isn't the blocker. Realism and repeatability are. Done properly, Tier-2 is a straightforward upgrade on what they already buy: serious, structured, annual, and connected back to the life they return to.
For both groups, a programme at a mid four figure price once a year or every second year is an ordinary business and life decision, not an indulgence.
Engine two: the Portuguese core
Group three, local professionals, chosen as a constraint on purpose. The average Portuguese household is not who I have in mind here. The group I care about is narrower: founders and senior operators in Lisbon and Porto, professionals already paying for private insurance, a gym and some diagnostics, willing to put a sensible annual amount towards staying functional.
I don't need most of the locals. What I need to learn is whether several hundred committed people would buy a structured prevention product, priced well away from Swiss levels, and then come back and buy it again.
That group is the honesty mechanism. They force the pricing to stay sane, they smooth out the seasons, and they tell you the truth about the clinical work. You can get away with a great deal for someone passing through. You can get away with nothing at all for someone who lives nearby and comes back the following year.
If it works for all three groups, it isn't a niche. It's a template.
Portugal as a test environment, not a postcode
Portugal isn't simply where I happen to live. It's part of the strategy, and I've written about what building here actually involves in more practical terms elsewhere.
Economically, growth here has run ahead of the euro area for several years, with the public budget in surplus and the debt stock back under 100% of GDP. Not a perfect system. One carrying some headroom and some momentum.
On health specifically, coverage from the public system is broad, and the private sector delivers good quality at price points below much of Western Europe. There's already a mix of medical travel and health tourism around Lisbon, Cascais and the Algarve.
On travel, a direct flight puts New York roughly seven to eight hours out, European capitals connect frequently, and an evening departure from the east coast lands you here by morning, in time to start a structured programme that same day.
Then add the rest. Operating costs sit below London, Zurich or New York. The tourism reputation reaches beyond cheap weekends. And there's an expanding community of founders and remote workers who picked this place for themselves.
Put it together and this isn't a lifestyle decision dressed up as strategy. It's a disciplined place to run the test. Large enough, and expanding fast enough, to be worth the effort. Short of supply in precisely the category I want to build. And close enough that clients elsewhere aren't rearranging their lives to get here.
Make it work here on sober assumptions and the playbook travels. Repeat it where the conditions look similar. Work with employers and insurers who need a prevention story they can stand behind. Put software on top of a workflow that already functions. This was never a one clinic story. It's a pattern of infrastructure, and it fits between the top layer and the acute layer in a great many countries.
The bet, said plainly
The business is still in stealth, so the full blueprint stays where it is. The bet itself I can state.
There's a structural gap between the noise of Tier-0 and Tier-1 and the reality of Tier-3.
Demand already shows up in behaviour, not only in surveys and slide decks.
The models that look Tier-2-ish mostly stop at better access, rather than reaching programmes engineered for outcomes and for scale.
A model respecting regulation, clinician time and liability can work, provided the segment and the geography are chosen carefully.
Portugal is a rational place to prove it first.
I don't hold this as a loose hypothesis. Behaviour points one way. So do the incentives, and so does the half built collection of partial answers already on the market. This layer is going to arrive with me or without me. My job is to turn something that looks inevitable into a disciplined working template, rather than a moodboard.
Execution can go wrong in a great many ways, and that's where I expect to be taught something. The category, though, isn't up for debate.
The four part lens I use to stay honest
To keep myself from drifting, I check decisions against four things.
Biology. What actually shifts function, and the risk of disease.
Friction. Liability. Regulation. Who is allowed to bill for what. Whether the workforce exists.
Experience. How it lands, and whether anybody chooses to come back.
Capital. Who is paying, at what level, and which story they think the money buys them.
Tier-0 barely looks at the stack at all and hopes for the best. Tier-1 polishes the last two, gestures towards biology, waves at friction. Tier-3 lives inside biology and friction, and has to scrap for the other two. Tier-2 only works if all four are engineered from the beginning. That's the actual work. The marble isn't. Nor is the sauna, nor the stack of supplements.
Where this argument is judgement rather than proof
It's worth being precise about what kind of claim this piece is making, because that determines how much weight it can carry.
Most of it is a structural argument, not a review of evidence. I'm reasoning from how the layers are built, how they're paid for, and what people do with their own money. An argument of that kind can be wrong in ways a trial result can't, and it's fair to hold it to that standard.
The thinnest part is the outcome question, and I said so above. In the models that already exist, what I can see is higher satisfaction and more preventive services actually taken up. What I can't put in front of you is a steady signal that strokes are avoided, that cancers get caught earlier, or that people end up with more functional years. Tier-2 is a bet that a designed programme beats opportunistic prevention. It isn't yet a demonstrated result, and anybody selling it as one has skipped a step.
The second honest limit is that more testing isn't automatically more prevention. That's why the conservatism above isn't decoration. A menu that mixes guideline screening with panels and scans that aren't recommended produces findings somebody then has to chase, and the person carrying it is the reader, not the brochure.
What would change my mind. If concierge and executive medicine began producing durable programme structures and outcome data, rather than access and attention, then the gap I'm describing would close on its own. If regulatory altitude turns out to be unstable, so that an operator in this layer gets pulled into hospital grade requirements by default, the economics stop working at this price. Both are live risks. Neither has happened yet.
Questions people ask about this
What does Tier-2 actually mean?
It's the layer that handles prevention properly for people who aren't ill yet: outside the hospital, tied to evidence, and built to come round again next year. In practice that means preparation before arrival, diagnostics done face to face, a protocol somebody actually drew up rather than assembled, and follow-through that runs for months around a job and a family.
How is that different from a concierge doctor?
Concierge sells access and time, and it sells them well. Prevention inside it tends to be opportunistic, picked up while you happen to be in the building. Tier-2 makes the programme itself the product, with a defined rationale for every test and an agreed route for escalation. That's a different thing from a longer appointment.
Is this a longevity clinic?
No. Tier-1 clinics compete on access, equipment and surroundings. What I'm describing is deliberately less photogenic and built to repeat at a price a professional can carry annually. I walked away from the Tier-1 version because it scaled badly, and because I wouldn't have been its repeat customer.
What would it cost, and how often?
The format I'm designing for repeats annually, or every second year, at a mid four figure price. For the people described above that's a rational line in the budget. A reset week costing twenty thousand euros is a different proposition entirely, and it's the one I decided against building.
Why start in Portugal?
Broad public coverage alongside a private sector delivering good quality at prices below much of Western Europe, operating costs below London, Zurich or New York, direct flights putting New York seven to eight hours away, and an existing mix of medical travel and health tourism. It's under-built in exactly this category, which makes it a test environment rather than a preference.
Those three realisations, about how Tier-1 scales, about which tools have a spine, and about my own place as a customer, are why my time and my capital are going into Tier-2, quietly, in Portugal. It's what the method we're building is trying to be, in practice rather than on a moodboard.
Executed well, this does more than avoid failure. It becomes the ordinary standard for what prevention looks like for working adults. Ten years from now I expect the label, or something close to it, to be unremarkable in health system decks. What I care about is that the template underneath is disciplined, humane and boringly repeatable. If your own work sits anywhere near this layer, whether you're building it, funding it or practising inside it, I'd be glad to hear from you.
This is an educational and strategic perspective, not personal medical advice. The views are the author's own and not statements by Atlas Cove Lda.
Lisa Wuerden · Co-Founder
Co-founder, brand and product
Read next
How to improve retention in a longevity business: design for joyspan
Clients leave when the week still feels the same. Joyspan is the third span that decides adherence, retention and referral in a health business.
The longevity market map: why the mid-priced tier is still missing
A market map of preventive health: what the top tier has proved, what the consumer layer misses, and why the mid-priced layer is still unbuilt.
Sleep architecture, not sleep hours: what a shortened night actually costs
Cutting a night short does not cost every sleep stage equally. What the evidence says about deep sleep, REM, alcohol, caffeine and sleep trackers.